Print to PDF
  • About Us
  • Privacy
  • Contact Us

Contact Lens Update

Clinical Insights Based in Current Research

Search Our Site

  • Home
  • Browse Past Issues
  • Resource Library
  • Back to Basics
  • Useful Links
  • About Us
  • Contact Us

Summary: Management and therapy report

October 6th, 2017

Download PDF

Mike YangMike Yang is a clinical researcher at the Centre for Contact Lens Research, in the School of Optometry and Vision Science at the University of Waterloo.

Jones L, Downie LE, et al.: TFOS DEWS II Management and Therapy Report. Ocul Surf 2017; 15(3): 575-628.

Advances in our understanding of the risk factors, etiology and pathophysiology of dry eye disease have contributed to an evolution in treatment strategies over time. A step-wise approach to dry eye management has been crafted based on extensive reviews of current evidence on dry eye therapies.

Assessing dry eye

Since appropriate diagnosis has a significant bearing on subsequent management, the first step involves assessing symptoms and analyzing dry eye risk factors. Then, diagnostic tests are utilized to subtype dry eye disease into evaporative dry eye (EDE) or aqueous deficient dry eye (ADDE). It is generally recognized that patients with dry eye disease do not fall into these two distinct categories but rather suffer from a combination of both EDE and ADDE; nevertheless, locating the disease along the EDE-ADDE spectrum is an important step in guiding therapy.

Staged management

Dry eye therapies are staged based on severity of the disease. The management algorithm presented in this report does not represent a rigid stepwise approach, but rather should be viewed as an organizational tool to use when initiating treatment of dry eye disease, to select interventions likely to provide most benefit.

First line treatment includes education regarding management and prognosis, modification of local environment and diet, ocular lubricants (consider lipid-containing supplement if meibomian gland disease is present), lid hygiene, hot compresses and elimination of offending systemic and topical medications.

If these options are inadequate consider non-preserved ocular lubricants, demodex treatment, tear conservation through punctal occlusion or moisture chambers, in-office treatment of meibomian glands, and pharmacological agents such as azithromycin and corticosteroids.

If the disease is still not adequately controlled, management may move towards oral secretagogues, autologous serum drops and therapeutic contact lens options.

For the most severe disease, treatment options include topical corticosteroid for long duration, amniotic membrane grafts, and other surgical approaches.

In summary, dry eye disease is a complex condition that varies, both in severity and in character, from patient to patient, and management should be adapted by eye care practitioners to best suit individual patients.

REFERENCES

Jones L, Downie LE, et al.: TFOS DEWS II Management and Therapy Report. Ocul Surf 2017; 15(3): 575-628.

For further details, please refer to The TFOS DEWS II Management and therapy

Issues

  • Multifocal Contact Lenses
  • Artificial Tears: An Update
  • Myopia: New Evidence and Best Practices
  • Neuropathic Pain
  • Specialty Rigid Lenses
  • Contact lens compliance
  • Pandemic update
  • Digital Devices and Dry Eye: A Growing Issue
  • The long and short of axial length
  • Using BCLA CLEAR with your patients
  • Helping your patients through allergy season
  • Getting the measure of meibomian glands
  • 2020: An extraordinary year
  • Scleral lens update
  • A dose of myopia
  • New news since TFOS DEWS II
  • COVID-19 Special Edition
  • Material considerations
  • Putting dry eye theory into practice
  • Getting started with Ortho-K
  • Infiltrates – an update
  • Staining
  • Myopia matters: Summarising the IMI reports
  • Lids and contact lenses
  • Myths
  • Revisiting patient compliance
  • Contact Lenses & Kids
  • Interprofessional Collaboration
  • Digital eye strain
  • New Dry Eye Technology
  • Update on Presbyopia
  • Taking stock of dry eye disease: DEWS II
  • Scleral Lenses
  • Pain and Sensation
  • Lab measurements in clinical practice
  • Control of pediatric myopia
  • Nutrition
  • Rethinking contact lens deposits
  • Extended wear
  • Daily Disposables
  • Eyelash Mites (Demodex)
  • Outsmarting bacteria with new technology
  • Youth and contact lenses
  • Sports Vision
  • Ocular effects of UV radiation from the sun
  • Eyelid Conditions
  • Makeup: Impact on ocular health
  • Myopia Control – Update 2014
  • The Growing Prevalence of Myopia
  • Cosmetic contact lenses
  • Contact lens discomfort – The essentials
  • Technology and contact lens research
  • It's A Question of Comfort
  • Contact lens materials
  • Let's talk about SICS
  • Conjunctival Controversies
  • Kids & Contact Lenses
  • One-day silicone hydrogel lenses
  • Solutions
  • Spotlight on Scleral lenses
  • Drug delivery via contact lenses
  • Ocular allergies
  • Reducing lens case contamination
  • Dry eye and meibomium gland dysfunction
  • Myopia Control
  • Presbyopia
  • Compliance and non-compliance
  • Lens care
  • Celebrating 50 years of contact lenses

Looking for another article?

Alcon coopervision Johnson&Johnson Vision Care

Newsletter Sign-Up

Sign-up for and start receiving our newsletter.

Site Map

  • Home
  • Browse Past Issues
    • Editorial
    • Feature Article
    • Clinical Insight
    • Conference Highlights
  • Resource Library
  • Back to Basics
  • Useful Links
  • About Us
  • Contact Us
© 2023 Contact Lens Update